Aashini’s Story

The best of both worlds for Aashini’s eyes

Aashini struggling to see the whiteboard was the first sign to her parents that she was developing nearsightedness. But Ahanitha, Aashini’s mother, says she wasn’t surprised. “My husband and I both have myopia, so Aashini’s more likely to become nearsighted as well.” In fact, when one parent is nearsighted, a child is 3x more likely to develop the condition1, and when both parents are nearsighted, as is the case for Aashini, the child is 6x more likely.2

“My own prescription is -2.00. That Aashini’s prescription has already surpassed mine made me very concerned for the future of her eye health.”

Despite consistent doctor check-ups and new glasses, Aashini’s myopia rapidly progressed from -1.00 to -2.50. This is when Ahanitha began to worry.

Severe myopia can lead to irreversible conditions like glaucoma, cataracts, retinal detachment, and macular degeneration.3 “I knew that her risk for other serious eye conditions was increasing with every diopter,” she says. When MiSight® 1 day contact lenses became available, Aashini’s parents didn’t hesitate to try the daily disposable contact lenses that are designed specifically for myopia control in age-appropriate children.4

What made MiSight® 1 day* contact lenses by CooperVision® appealing to Aashini’s parents was that they offered “the best of both worlds.” Specially crafted for children who have myopia, these contact lenses correct distance vision immediately5 and slow the progression of myopia in children aged 8–12 at the initiation of treatment.†4 All this, while giving her the freedom to pursue her various activities and interests without discomfort or inconvenience.6 This was a massive win for Aashini who marvels at the lenses’ ease4 and comfort7: “They don’t bother me when I read a book, play sports, or use the computer.”

For her parents, “MiSight® 1 day has been a game changer.” The lenses have given Aashini and her parents peace of mind, because they know her myopia is under control. Ahanitha puts it simply. “It feels good knowing there’s something that we can do for our daughter’s eye health.”

Learn more at the Myopia Blog

Photograph of mother and daughter.

What is myopia? Causes, warning signs, risks and solutions

If you’ve heard of myopia, you probably already know it has something to do with vision—even if you’re unsure exactly what it is. Myopia is a common vision condition in children...

Photograph of mother and daughter.

MiSight® 1 day vs. Single Vision Contact Lenses: Why Parents are Choosing a Contact Lens that Does More

If your child has been diagnosed with myopia (nearsightedness), you’ve probably already noticed how quickly prescriptions can change. 1 Not all contact lenses work the same way...

Photograph of a girl looking through a helmet.

The Winning Edge: How Contact Lenses Can Boost Young Athletes' Vision and Performance

Clear vision is essential for young athletes when it comes to their ability to perform in sports and their active lifestyles. MiSight® 1 day contact lenses for myopia control...

Photograph of a boy taking an eye exam.

What are the Risks of High Myopia?

The blurred vision that comes with nearsightedness, also known as myopia, can sometimes be little more than an inconvenience. But in some cases, it can also put your eye health at...

*INDICATIONS AND BRIEF SAFETY INFORMATION for MiSight® 1 day soft contact lens:

INDICATIONS: 
MiSight® 1 day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75D to -4.00D (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

BRIEF SAFETY INFORMATION: Rx only; results may vary.

ATTENTION: Reference the Patient Information Brochure or visit misight.com/safety for a complete listing of Indications and Important Safety Information.

WARNINGS: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances, MiSight® lenses’ optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulty with certain visually demanding tasks.

PRECAUTIONS: Daily wear single use only. Patient should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities.

ADVERSE EVENTS: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.

References:

  1. Jiang, X., Tarczy-Hornoch, K., Cotter, S.A., et al. Association of Parental Myopia With Higher Risk of Myopia Among Multiethnic Children Before School Age [published online ahead of print, 2020 Mar 19]. JAMA Ophthalmol. 2020;138(5):1-9.
  2. Mutti, D.O., Mitchell, G.L., Moeschberger, M.L., Jones, L.A., Zadnik, K. Parental myopia, near work, school achievement, and children's refractive error. Invest Ophthalmol Vis Sci. 2002; 43(12):3633-3640. doi:10.1001/jamaophthalmol.2020.0412
  3. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622-60.
  4. Chamberlain, P., et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. (2019); 96(8):556-567.
  5. Rah, M.J., et al. Vision-specific quality of life of pediatric contact lens wearers. Optom Vis Sci2010;87(8):560-6.
  6. Walline, J.J., et al. Benefits of contact lens wear for children and teens. Eye Contact Lens. 2007; 33(6 Pt 1):317-21.
  7. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.

 

12433